Applied Clinical Trials Digital Edition - July 2012
Regulatory: Developing Biosimilars for a Global Market Subject Recruitment: Patient Interest in Clinical Trial Referral CRO/Sponsor: Functional Service Provider Model Also in this issue: Proposed Rule Changes in Europe Global Study Monitors Benchmarks Emergency Department Trials
Articles in this issue
Managing Budgets in Complex Times with Tight Variances
Act cover
Business and News Update July 2012
Increasing Intensity of On-Site Monitoring a Troubling Trend
Drug Information? Forget it!
Supply Chain Management
Developing Quality Biosimilars
Drivers of Patient Interest in Referral
Risk-Based Monitoring Risky for Sponsors?
Fresh Doubts Cast Over Post-Marketing Trials
Health Reform Declared Constitutional
Flying Blind on CRA Workload, Time Demands
Emergency Department Setting Trials
Ethical, Logistical Issues: Experts Outline Criteria to Justify Randomized Studies
Applied Clinical Trials Digital Edition - July 2012
Recent Videos
Related Content
Unifying Industry to Better Understand GCP Guidance
May 7th 2025Podcast
In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
